Open terminalDashboard

Last updated Nov 19, 6:58 AM ET · 1 update

Merck Partners With Isomorphic Labs on AI Drug Discovery

Merck announced a research collaboration with Isomorphic Labs to apply artificial intelligence to drug discovery, the company said Thursday.

More on this company

  1. Merck said Thursday, in a release distributed by Business Wire, that it has entered a research collaboration with Isomorphic Labs, an artificial intelligence-focused drug design company.

What happened

Merck, which operates as MSD outside the United States and Canada, said in its release that it is teaming up with Isomorphic Labs, a company that uses artificial intelligence to design and develop drugs. According to the companies' joint statement, the collaboration will pair Isomorphic Labs' artificial-intelligence approach to drug discovery with Merck's proprietary data and its experience in early-stage research. Merck said the two firms will work together to discover new medicines, though the release did not specify which disease areas or compounds are involved.

How the stock has moved

Merck shares traded at $137.28 in pre-market trading, down 0.36% from Wednesday's close of $137.78, the same percentage move recorded since the collaboration was first reported.

Merck & Co. (MRK) since the news
MeasureValue
Price, pre-market trading$137.28
Since the close before the first report (Wednesday, November 18, 2026)-0.36%
Change from the close on Wednesday, November 18, 2026-0.36%
Market value at the close on Wednesday, November 18, 2026$339.66 billion

Source: Stock quote; the close before the first report from our saved closes · as of November 19, 2026 at 6:58 AM ET · Shows what the stock did after the news was first reported, not why.

Its suppliers and customers

Company filings list Doctor Fultz Pharma, Verona Pharma and Sidera Therapeutics as suppliers to Merck; none of the three, which are not publicly listed, has recorded a trade since its last close.

Suppliers and customers of Merck, and how they are trading
CompanyRoleStockSince last close
Doctor Fultz PharmaSupplierNot listed—
Verona PharmaSupplierNot listed—
Sidera TherapeuticsSupplierNot listed—

Source: Relationships named in company filings (Earnings call transcript); stock quotes · as of November 19, 2026 at 6:58 AM ET · A supplier or customer moving the same day is not evidence that one move caused the other.

Sources

  • — Business Wire

How this was made

Written from WiseView data and the sources credited above, and checked before it went up. It is updated as new reports come in, and every update is checked before it goes up. How this report is made

For information only, not investment advice.

More from the desk

Follow MRK in the terminal.

Every panel, HootAI, the squawk and the pre-market board, on one membership.

Annual

$83/mo

Billed annually, $997 once a year.

Monthly

$127/mo

Billed monthly. Cancel any time.

14-day free trial · no card needed · nothing to cancel. Buying for a team? Seats on one invoice.